Ruggero Fariello
Corporate Officer/Principal bei SeneXta Therapeutics SA
Profil
Ruggero Fariello is the founder of Newron Pharmaceuticals SpA, which was founded in 1999.
He held the title of Non-Executive Director from 1999 to 2007.
Dr. Fariello is currently a Member-Executive Board at SeneXta Therapeutics SA, starting in 2008.
Dr. Fariello has held former positions as Chairman & Professor at Rush University, Director-Research & Development at CNS, Inc. (Delaware), Director-Research & Development at Thomas Jefferson University, Senior Consultant at Pharmacia & Upjohn, Inc., and Chief Medical Officer at Neurotune AG.
Dr. Fariello obtained a doctorate degree from the University of Turin in 1965.
Aktive Positionen von Ruggero Fariello
Unternehmen | Position | Beginn |
---|---|---|
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Corporate Officer/Principal | 18.09.2009 |
Ehemalige bekannte Positionen von Ruggero Fariello
Unternehmen | Position | Ende |
---|---|---|
NEWRON PHARMACEUTICALS S.P.A. | Gründer | 21.05.2007 |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 20.02.2013 |
Thomas Jefferson University | Technik-/Wissenschafts-/F&E-Leiter | - |
Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
CNS, Inc. (Delaware)
CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ruggero Fariello
University of Turin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
Private Unternehmen | 4 |
---|---|
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
CNS, Inc. (Delaware)
CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Retail Trade |
Pharmacia & Upjohn, Inc. | Health Technology |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |